ATS Breathe Easy

Artificial intelligence is at the center of dozens of new tools and technological advances, but how should clinicians and researchers integrate them into their practice and research? The ATS AI Taskforce was formed to help answer this question, explore the latest innovations in the space, and how it fits into the needs of ATS members. Shirin Shafazand, MD, MS, FAASM, ATSF, University of Miami, and past-president of the ATS David Gozal, MD, MBA, Marshall University, join host Eddie Qian, MD, Vanderbilt University, to discuss this new taskforce, talk about AI programming at ATS 2026, and how AI is helping to shape the future of medicine.

April is Sarcoidosis Awareness Month! Host Patti Tripathi speaks with Mary McGowan, president and CEO of the Foundation for Sarcoidosis Research, about the importance of continuing research on sarcoidosis, advocacy and policy efforts in the field, and fighting for paid leave for those participating in clinical trials.
Learn more about the Foundation for Sarcoidosis Research at https://www.stopsarcoidosis.org/
Learn more about The Champions for Change: https://site.thoracic.org/press-releases/champions-for-change-paid-time-off-initiative-just-made-clinical-trials-participation-easier
Learn more about the bipartisan Congressional Sarcoidosis Caucus: https://gottheimer.house.gov/posts/release-gottheimer-launches-bipartisan-sarcoidosis-caucus-to-battle-the-debilitating-disease-in-memory-of-his-mother

The U.S. Environmental Protection Agency (EPA) changed the dollar value of a statistical life in January 2026, essentially dropping it to zero. What does that mean for the average American? As Anthony Gerber, MD, PhD, University of Kentucky, explains to Air Health Our Health host Erika Moseson, MD, MA, this means the agency will no longer account for the healthcare costs of air pollution and lost lives when determining how account how clean air policies and other key legislation affect communities. In this conclusion of a two-part series on the EPA’s dollar value of a statistical life, Dr. Gerber explains what this change means and why is it significant.

The U.S. Environmental Protection Agency (EPA) changed the dollar value of a statistical life in January 2026, essentially dropping it to zero. What does that mean for the average American? As Anthony Gerber, MD, PhD, University of Kentucky, explains to Air Health Our Health host Erika Moseson, MD, MA, this means the agency will no longer account for the healthcare costs of air pollution and lost lives when determining how account how clean air policies and other key legislation affect communities. In this first part of a two-part series on the EPA’s dollar value of a statistical life, Dr. Gerber explains what this change means and why is it significant.

How can peers help those in their field entering mid-career? Through the sharing of their successes and struggles. This was the solution Joshua Lee Denson, MD, MS, Tulane University, and colleagues came up with when asked for event ideas for the ATS International Conference. The ATS Storytelling Series has been a huge success, giving mid-career professionals a space to highlight wins, discuss issues, and connect with a community of professionals looking to advance and expand. Dr. Denson and host Amy Attaway, MD, Cleveland Clinic, talk about how this series was developed, how it has helped others in the past, and what to look forward to at ATS 2026. 
Be sure to register for ATS 2026: https://registration.experientevent.com/ShowATS261/Flow/ATT?atslogin=1&marketingcode=YOUTUBE